Results 181 to 190 of about 6,778,204 (293)
Systematic profiling of cancer‐fibroblast interactions reveals drug combinations in ovarian cancer
Molecular Oncology, EarlyView.Fibroblasts, cells in the tumor environment, support ovarian cancer cell growth and alter morphology and drug response. We used fibroblast and cancer cell co‐culture models to test 528 drugs and discovered new drugs for combination treatment. We showed that adding Vorinostat or Birinapant to standard chemotherapy may improve drug response, suggesting ...
Greta Gudoityte +10 more
wiley +1 more source
Molecular Oncology, EarlyView.The COMBAT classification system, developed through multi‐omics integration, stratifies adult patients with B‐cell acute lymphoblastic leukemia(B‐ALL) into three molecular subtypes with distinct surface antigen patterns, immune landscape, methylation patterns, biological pathways and prognosis.
Yang Song +11 more
wiley +1 more source
Molecular Oncology, EarlyView.In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton +17 more
wiley +1 more source
Worthwhile or Not? The Pain-Gain Ratio of Screening Routine cMRIs in a Maximum Care University Hospital for Incidental Intracranial Aneurysms Using Artificial Intelligence. [PDF]
J Clin MedMueller F +16 more
europepmc +1 more source
100. Note on the Two Hexacoralla, Goniocorella dumosa (Alcock) and Bantamia gerthi, gn. et sp. nov
, 1943 Hisakatsu YABE, Motoki Eguchi
openalex +2 more sources
Biochimica et Biophysica Acta, Volume 1, No. 1, (1947). Elsevier, New York–Amsterdam; Interscience, New York. 100 pp. Price $9.00 (annual subscription, 6 to 8 issues) [PDF]
, 1947 Kurt G. Stern
openalex +1 more source